Progress and Challenges in Quantifying Carbonyl-Metabolomic Phenomes with LC-MS/MS

Area of Science:

• Metabolomics
• Analytical Chemistry
• Biochemistry

Background:

• Carbonyl-containing metabolites are vital in biological systems, necessitating precise quantification for understanding metabolic pathways and diseases.
• Direct analysis of carbonyls via reversed-phase liquid chromatography-electrospray ionization-mass spectrometry (RPLC-ESI-MS) is hindered by poor ionization efficiency.
• Traditional chemical derivatization improves sensitivity but struggles with accurate quantification due to instrument drift and matrix effects.

Purpose of the Study:

• To review the application of stable isotope-coded derivatization (ICD) for the sensitive and accurate quantification of carbonyl-containing metabolites.
• To highlight the advantages of ICD in LC-MS-based metabolomics, including targeted analysis, untargeted profiling, and multiplexed submetabolome analysis.

Main Methods:

• Utilizing stable isotope-coded derivatization (ICD) reagents to modify carbonyl-containing metabolites.
• Employing liquid chromatography-mass spectrometry (LC-MS) for the separation and detection of derivatized metabolites.
• Discussing representative derivatization reagents and their applications in quantitative analysis and submetabolome profiling.

Main Results:

• ICD effectively overcomes the sensitivity limitations of direct RPLC-ESI-MS analysis for carbonyls.
• ICD enables accurate quantification by mitigating instrument drift and matrix effects.
• ICD facilitates multiplexed or multichannel submetabolome analysis, reducing analysis time and MS response variation.

Conclusions:

• Stable isotope-coded derivatization is a superior strategy for the sensitive and accurate detection of carbonyl-containing metabolites.
• ICD-based LC-MS methods are powerful tools for both targeted quantification and untargeted profiling in metabolomics.
• The ICD approach offers significant advantages for comprehensive analysis of carbonyl-containing metabolic pathways and disease mechanisms.